325 related articles for article (PubMed ID: 18628527)
1. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.
Gejman R; Batista DL; Zhong Y; Zhou Y; Zhang X; Swearingen B; Stratakis CA; Hedley-Whyte ET; Klibanski A
J Clin Endocrinol Metab; 2008 Oct; 93(10):4119-25. PubMed ID: 18628527
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.
Cheunsuchon P; Zhou Y; Zhang X; Lee H; Chen W; Nakayama Y; Rice KA; Tessa Hedley-Whyte E; Swearingen B; Klibanski A
Am J Pathol; 2011 Oct; 179(4):2120-30. PubMed ID: 21871428
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of GADD45γ, MEG3, and p8 in pituitary adenomas.
Binse I; Ueberberg B; Sandalcioglu IE; Flitsch J; Luedecke DK; Mann K; Petersenn S
Horm Metab Res; 2014 Aug; 46(9):644-50. PubMed ID: 25126861
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
[TBL] [Abstract][Full Text] [Related]
6. Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.
Kagami M; Yanagisawa A; Ota M; Matsuoka K; Nakamura A; Matsubara K; Nakabayashi K; Takada S; Fukami M; Ogata T
Clin Epigenetics; 2019 Mar; 11(1):42. PubMed ID: 30846001
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
8. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas.
Mezzomo LC; Gonzales PH; Pesce FG; Kretzmann Filho N; Ferreira NP; Oliveira MC; Kohek MB
Pituitary; 2012 Sep; 15(3):420-7. PubMed ID: 21850407
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of delta-like homolog 1/maternally expressed gene 3 loci in human umbilical veins: insights into offspring vascular dysfunction born after preeclampsia.
Yu YC; Jiang Y; Yang MM; He SN; Xi X; Xu YT; Hu WS; Luo Q
J Hypertens; 2019 Mar; 37(3):581-589. PubMed ID: 30234781
[TBL] [Abstract][Full Text] [Related]
11. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
PLoS One; 2012; 7(11):e49462. PubMed ID: 23145177
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.
Zhao J; Dahle D; Zhou Y; Zhang X; Klibanski A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2179-86. PubMed ID: 15644399
[TBL] [Abstract][Full Text] [Related]
13. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone.
Lehner B; Kunz P; Saehr H; Fellenberg J
BMC Cancer; 2014 Jul; 14():495. PubMed ID: 25005035
[TBL] [Abstract][Full Text] [Related]
15. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
17. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
18. Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus.
Zhu W; Botticelli EM; Kery RE; Mao Y; Wang X; Yang A; Wang X; Zhou J; Zhang X; Soberman RJ; Klibanski A; Zhou Y
Dev Biol; 2019 Nov; 455(1):10-18. PubMed ID: 31301299
[TBL] [Abstract][Full Text] [Related]
19. Novel 14q32.2 paternal deletion encompassing the whole DLK1 gene associated with Temple syndrome.
Baena N; Monk D; Aguilera C; Fraga MF; Fernández AF; Gabau E; Corripio R; Capdevila N; Trujillo JP; Ruiz A; Guitart M
Clin Epigenetics; 2024 May; 16(1):62. PubMed ID: 38715103
[TBL] [Abstract][Full Text] [Related]
20. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.
Zhang X; Zhou Y; Mehta KR; Danila DC; Scolavino S; Johnson SR; Klibanski A
J Clin Endocrinol Metab; 2003 Nov; 88(11):5119-26. PubMed ID: 14602737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
